# Sutro Biopharma, Inc. (STRO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/STRO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 24.36M | $ -77.02M | $ -80.56M | N/A | $ -103.32M |
| 2025 | $ 104.93M | $ -195.66M | $ -183.20M | $ 235.21M | $ -132.45M |
| 2024 | $ 65.21M | $ -239.08M | $ -204.58M | $ 23.15M | $ 44.60M |
| 2023 | $ 166.22M | $ -115.47M | $ -125.35M | $ 33.64M | $ 149.65M |
| 2022 | $ 75.71M | $ -133.16M | $ -4.81M | $ 55.02M | $ 217.05M |
| 2021 | $ 73.55M | $ -125.45M | $ -115.30M | $ 57.37M | $ 252.56M |
| 2020 | $ 54.42M | $ -40.93M | $ -95.46M | $ 24.55M | $ 332.05M |
| 2019 | $ 55.16M | $ -71.95M | $ -88.42M | $ 9.88M | $ 97.79M |
| 2018 | $ 50.74M | $ -46.64M | $ 14.69M | $ 14.72M | $ 131.54M |
| 2017 | $ 69.70M | $ -26.52M | $ -54.41M | $ 14.63M | $ -109.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -2.88 |
| Current Ratio | 3.32 |

## Other views

- [Metrics](https://sponda.capital/en/STRO.md)
- [Charts](https://sponda.capital/en/STRO/charts.md)
- [Compare](https://sponda.capital/en/STRO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.